ClinicalTrials.Veeva

Menu

Virtual Reality Exposure for Public Speaking Anxiety (VRanx)

V

Vilnius University

Status

Enrolling

Conditions

Public Speaking Anxiety

Treatments

Behavioral: Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety

Study type

Interventional

Funder types

Other

Identifiers

NCT06214039
VRanx_001

Details and patient eligibility

About

This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • aged 18-30 and studying in higher education;
  • experiencing a significant level of public speaking anxiety (60+ on PSAS);
  • able to use a computer and have access to the internet for the duration of the study;
  • able to understand, write and speak in Lithuanian;
  • available to participate in one or three in-person intervention sessions and can devote the time to participate in a 4-week online program following the intervention sessions.

Exclusion criteria

  • a history of seizures or a history of epilepsy;
  • other significant medical conditions that would prevent them from participating in the program;
  • high levels of depression (Patient Health Questionnaire-9 rating of 15 and above and mentions of suicidal ideation) or other significant psychiatric conditions that would interfere with participation in the program;
  • a tendency to have extreme seasickness reactions or a history of adverse physical reactions to virtual reality experiences or difficulty with or lack of stereoscopic vision;
  • current involvement in other psychological interventions such as psychological counseling or psychotherapy;
  • use of psychoactive drugs, unless stable for three months;
  • current participation in other programs aimed at reducing public speaking anxiety.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

One session therapy
Active Comparator group
Description:
One session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand
Treatment:
Behavioral: Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety
One session therapy - divided into 3
Experimental group
Description:
Three session exposure therapy followed by 4 weeks of internet-delivered self-help with therapist support on demand
Treatment:
Behavioral: Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety

Trial contacts and locations

1

Loading...

Central trial contact

Jonas Eimontas, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems